EZH2 polymorphism and benefit from bevacizumab in colorectal cancer: Another piece to the puzzle

L. Fornaro; F. Crea; G. Masi; E. Paolicchi; F. Loupakis; F. Graziano; L. Salvatore; M. Ronzoni; V. Ricci; C. Cremolini; M. Schirripa; R. Danesi; A. Falcone

doi:10.1093/annonc/mds031

EZH2 polymorphism and benefit from bevacizumab in colorectal cancer: Another piece to the puzzle

L. Fornaro, F. Crea, G. Masi, E. Paolicchi, F. Loupakis, F. Graziano, L. Salvatore, M. Ronzoni, V. Ricci, C. Cremolini, M. Schirripa, R. Danesi, A. Falcone

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1370-1371
Number of pages	2
Journal	Annals of Oncology
Volume	23
Issue number	5
DOIs	https://doi.org/10.1093/annonc/mds031
Publication status	Published - May 2012

ASJC Scopus subject areas

Oncology
Hematology

Access to Document

10.1093/annonc/mds031

Cite this

EZH2 polymorphism and benefit from bevacizumab in colorectal cancer : Another piece to the puzzle. / Fornaro, L.; Crea, F.; Masi, G.; Paolicchi, E.; Loupakis, F.; Graziano, F.; Salvatore, L.; Ronzoni, M.; Ricci, V.; Cremolini, C.; Schirripa, M.; Danesi, R.; Falcone, A.

In: Annals of Oncology, Vol. 23, No. 5, 05.2012, p. 1370-1371.

Research output: Contribution to journal › Article › peer-review

@article{dbecb19a69b5487abf8158dce47d13a1,

title = "EZH2 polymorphism and benefit from bevacizumab in colorectal cancer: Another piece to the puzzle",

author = "L. Fornaro and F. Crea and G. Masi and E. Paolicchi and F. Loupakis and F. Graziano and L. Salvatore and M. Ronzoni and V. Ricci and C. Cremolini and M. Schirripa and R. Danesi and A. Falcone",

year = "2012",

month = may,

doi = "10.1093/annonc/mds031",

language = "English",

volume = "23",

pages = "1370--1371",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

number = "5",

}

TY - JOUR

T1 - EZH2 polymorphism and benefit from bevacizumab in colorectal cancer

T2 - Another piece to the puzzle

AU - Fornaro, L.

AU - Crea, F.

AU - Masi, G.

AU - Paolicchi, E.

AU - Loupakis, F.

AU - Graziano, F.

AU - Salvatore, L.

AU - Ronzoni, M.

AU - Ricci, V.

AU - Cremolini, C.

AU - Schirripa, M.

AU - Danesi, R.

AU - Falcone, A.

PY - 2012/5

Y1 - 2012/5

UR - http://www.scopus.com/inward/record.url?scp=84860436211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860436211&partnerID=8YFLogxK

U2 - 10.1093/annonc/mds031

DO - 10.1093/annonc/mds031

M3 - Article

C2 - 22383679

AN - SCOPUS:84860436211

VL - 23

SP - 1370

EP - 1371

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 5

ER -

EZH2 polymorphism and benefit from bevacizumab in colorectal cancer: Another piece to the puzzle

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this